{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:06:10Z","timestamp":1793192770596,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00428-023-03710-7","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T07:02:53Z","timestamp":1702623773000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular features for timely cancer diagnosis and treatment \u2013 tumors of the ovary, fallopian tube and endometrium"],"prefix":"10.1007","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-6010","authenticated-orcid":false,"given":"Sonia","family":"Gatius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-8427","authenticated-orcid":false,"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"3","key":"3710_CR1","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.modpat.2022.100049","volume":"36","author":"S Fox","year":"2023","unstructured":"Fox S, Doig KD, Fellowes AP (2023) \u201cHomologous Recombination Repair Deficiency: An Overview for Pathologists.,.\u201d Mod Pathol 36(3):100049. https:\/\/doi.org\/10.1016\/j.modpat.2022.100049","journal-title":"Mod Pathol"},{"key":"3710_CR2","doi-asserted-by":"publisher","unstructured":"Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA (2022) Ovarian cancer therapy: homologous recombination deficiency as a predictive biomarker of response to PARP inhibitors. Onco Targets Ther 15:1105\u20131117. https:\/\/doi.org\/10.2147\/OTT.S272199","DOI":"10.2147\/OTT.S272199"},{"issue":"20","key":"3710_CR3","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-20-1268","volume":"26","author":"P Kr\u00e4mer","year":"2020","unstructured":"Kr\u00e4mer P, Talhouk A, Brett MA, Chiu DS, Cairns ES, Scheunhage DA, Hammond RFL, Farnell D, Nazeran TM, Grube M, Xia Z, Senz J, Leung S, Feil L, Pasternak J, Dixon K, Hartkopf A, Kr\u00e4mer B, Brucker S, Heitz F, du Bois A, Harter P, Kommoss FKF, Sinn HP, Heublein S, Kommoss F, Vollert HW, Manchanda R, de Kroon CD, Nijman HW, de Bruyn M, Thompson EF, Bashashati A, McAlpine JN, Singh N, Tinker AV, Staebler A, Bosse T, Kommoss S, K\u00f6bel M, Anglesio MS (2020) Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma. Clin Cancer Res 26(20):5400\u20135410. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1268","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3710_CR4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/modpathol.2017.81","volume":"30","author":"S Nofech-Mozes","year":"2017","unstructured":"Nofech-Mozes S, Parra-Herran C, Lerner-Ellis J, Xu B, Khalouei S, Bassiouny D, Cesari M, Ismiil N (2017) Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups. Mod Pathol. 30(12):1748\u20131759. https:\/\/doi.org\/10.1038\/modpathol.2017.81","journal-title":"Mod Pathol."},{"issue":"7","key":"3710_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/PAS.0000000000001478","volume":"44","author":"J Palacios","year":"2020","unstructured":"Palacios J, Leskela S, Romero I, Rosa-Rosa JM, Caniego-Casas T, Cristobal E, P\u00e9rez-Mies B, Gutierrez-Pecharroman A, Sant\u00f3n A, Ojeda B, L\u00f3pez-Reig R, Palacios-Berraquero ML, Andrada E, Montes S, Pastor F, Gomez MC, L\u00f3pez-Guerrero JA, Poveda A (2020) Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification. Am J Surg Pathol. 44(7):982\u2013990. https:\/\/doi.org\/10.1097\/PAS.0000000000001478","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"3710_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1097\/PAS.0000000000001328","volume":"43","author":"S Nofech-Mozes","year":"2019","unstructured":"Nofech-Mozes S, Parra-Herran C, Bassiouny D, Lerner-Ellis J, Olkhov-Mitsel E, Ismiil N, Hogen L, Vicus D (2019) p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis. Am J Surg Pathol. 43(12):1591\u20131599. https:\/\/doi.org\/10.1097\/PAS.0000000000001328","journal-title":"Am J Surg Pathol."},{"issue":"22","key":"3710_CR7","doi-asserted-by":"publisher","first-page":"00198","DOI":"10.1016\/j.ygyno.2022.03.016","volume":"31S0090-8258","author":"H Lassus","year":"2022","unstructured":"Lassus H, Simil\u00e4-Maarala J, Soovares P, Pasanen A, Ahvenainen T, Vahteristo P, B\u00fctzow R (2022) TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma. Gynecol Oncol. 31S0090-8258(22):00198\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.016","journal-title":"Gynecol Oncol."},{"key":"3710_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2022.11.031","volume":"169","author":"C Di Dio","year":"2023","unstructured":"Di Dio C, Bogani G, Di Donato V, Cuccu I, Muzii L, Musacchio L, Scambia G, Lorusso D (2023) The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma. Gynecol Oncol 169:27\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2022.11.031","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3710_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11864-021-00904-6","volume":"22","author":"K Gorringe","year":"2021","unstructured":"Gorringe K, Craig O, Salazar C (2021) \u201cOptions for the Treatment of Mucinous Ovarian Carcinoma.,.\u201d Curr Treat Options Oncol 22(12):114. https:\/\/doi.org\/10.1007\/s11864-021-00904-6","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"3710_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ygyno.2019.12.033","volume":"156","author":"B Slomovitz","year":"2020","unstructured":"Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O\u2019Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fern\u00e1ndez ML, Ray-Coquard I, Gershenson DM (2020) Low-grade serous ovarian cancer: State of the science. Gynecol Oncol 156(3):715\u2013725. https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.033","journal-title":"Gynecol Oncol"},{"issue":"1\u20132","key":"3710_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mce.2011.06.019","volume":"356","author":"R Veitia","year":"2012","unstructured":"Veitia R, Caburet S, Georges A, L\u2019H\u00f4te D, Todeschini AL, Benayoun BA (2012) The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology. Mol Cell Endocrinol. 356(1\u20132):55\u201364. https:\/\/doi.org\/10.1016\/j.mce.2011.06.019","journal-title":"Mol Cell Endocrinol."},{"issue":"26","key":"3710_CR12","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","volume":"360","author":"D Huntsman","year":"2009","unstructured":"Huntsman D, Shah SP, K\u00f6bel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvil G (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360(26):2719\u201329. https:\/\/doi.org\/10.1056\/NEJMoa0902542","journal-title":"N Engl J Med"},{"issue":"9","key":"3710_CR13","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/PAS.0b013e31828e4f55","volume":"37","author":"C Gilks","year":"2013","unstructured":"Gilks C, McCluggage WG, Singh N, Kommoss S, Huntsman DG (2013) Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor. Am J Surg Pathol. 37(9):1450\u20135. https:\/\/doi.org\/10.1097\/PAS.0b013e31828e4f55","journal-title":"Am J Surg Pathol."},{"issue":"5","key":"3710_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/PAS.0000000000001232","volume":"43","author":"F Kommoss","year":"2019","unstructured":"Kommoss F, Karnezis AN, Wang Y, Keul J, Tessier-Cloutier B, Magrill J, Kommoss S, Senz J, Yang W, Proctor L, Schmidt D, Clement PB, Gilks CB, Huntsman DG (2019) DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. Am J Surg Pathol. 43(5):628\u2013638. https:\/\/doi.org\/10.1097\/PAS.0000000000001232","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"3710_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/his.12747","volume":"68","author":"R Rimokh","year":"2016","unstructured":"Rimokh R, Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu MC, Pujade-Laurraine E, Savina A, Maillet D, Gillet G, Treilleux I (2016) DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathol. 68(2):279\u201385. https:\/\/doi.org\/10.1111\/his.12747","journal-title":"Histopathol."},{"issue":"3","key":"3710_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cjp2.198","volume":"7","author":"D Huntsman","year":"2021","unstructured":"Huntsman D, Pilsworth JA, Cochrane DR, Neilson SJ, Moussavi BH, Lai D, Munzur AD, Senz J, Wang YK, Zareian S, Bashashati A, Wong A, Keul J, Staebler A, van Meurs HS, Horlings HM, Kommoss S, Kommoss F, Oliva E, F\u00e4rkkil\u00e4 AE, Gilks B (2021) Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease. J Pathol Clin Res. 7(3):243\u2013252. https:\/\/doi.org\/10.1002\/cjp2.198","journal-title":"J Pathol Clin Res."},{"issue":"10","key":"3710_CR17","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/genes13101761","volume":"13","author":"O Bodamer","year":"2022","unstructured":"Bodamer O, Barry KK, Tsaparlis M, Hoffman D, Hartman D, Adam MP, Hung C (2022) From Genotype to Phenotype-A Review of Kabuki Syndrome. Genes (Basel) 13(10):1761. https:\/\/doi.org\/10.3390\/genes13101761","journal-title":"Genes (Basel)"},{"issue":"2","key":"3710_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"N Sonenberg","year":"2008","unstructured":"Sonenberg N, Filipowicz W, Bhattacharyya SN (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9(2):102\u201314. https:\/\/doi.org\/10.1038\/nrg2290","journal-title":"Nat Rev Genet."},{"issue":"1","key":"3710_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41379-021-00905-8","volume":"35","author":"L Dehner","year":"2022","unstructured":"Dehner L, Gonz\u00e1lez IA, Stewart DR, Schultz KAP, Field AP, Hill DA (2022) DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol. 35(1):4\u201322. https:\/\/doi.org\/10.1038\/s41379-021-00905-8","journal-title":"Mod Pathol."},{"issue":"3","key":"3710_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1056\/NEJMoa1102903","volume":"366","author":"D Huntsman","year":"2012","unstructured":"Huntsman D, Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, Fejes AP, Chow C, Tone A, Kalloger SE, Hamel N, Roth A, Ha G, Wan AN, Maines-Bandiera S, Salamanca C, Pasini B, Clarke BA, Lee AF, Lee CH, Zhao C, Young RH, Aparicio SA, Sorensen PH, Wo MM (2012) Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 366(3):234\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1102903","journal-title":"N Engl J Med."},{"issue":"12","key":"3710_CR21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/modpathol.2015.115","volume":"28","author":"B Weigelt","year":"2015","unstructured":"Weigelt B, Conlon N, Schultheis AM, Piscuoglio S, Silva A, Guerra E, Tornos C, Reuter VE, Soslow RA, Young RH, Oliva E (2015) A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Mod Pathol. 28(12):1603\u201312. https:\/\/doi.org\/10.1038\/modpathol.2015.115","journal-title":"Mod Pathol."},{"issue":"9","key":"3710_CR22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/PAS.0000000000000895","volume":"41","author":"B Clarke","year":"2017","unstructured":"Clarke B, de Kock L, Terzic T, McCluggage WG, Stewart CJR, Shaw P, Foulkes WD (2017) DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. Am J Surg Pathol. 41(9):1178\u20131187. https:\/\/doi.org\/10.1097\/PAS.0000000000000895","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"3710_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/PAS.0000000000002010","volume":"47","author":"W Foulkes","year":"2023","unstructured":"Foulkes W, McCluggage WG, Rivera B, Chong AS, Clarke BA, Schultz KAP, Dehner LP, Tchrakian N, Apellaniz-Ruiz M, Gilks CB, Kommoss F, Stewart CJR (2023) Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs. Am J Surg Pathol. 47(4):490\u2013496. https:\/\/doi.org\/10.1097\/PAS.0000000000002010","journal-title":"Am J Surg Pathol."},{"issue":"6","key":"3710_CR24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/PAS.0000000000001442","volume":"44","author":"W Foulkes","year":"2020","unstructured":"Foulkes W, McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Vel\u00e1zquez Vega JE, McVeigh TP (2020) Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations. Am J Surg Pathol. 44(6):738\u2013747. https:\/\/doi.org\/10.1097\/PAS.0000000000001442","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"3710_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/PAS.0000000000001582","volume":"45","author":"M Devouassoux-Shisheboran","year":"2021","unstructured":"Devouassoux-Shisheboran M, Baillard P, Genestie C, Croce S, Descotes F, Rouleau E, Treilleux I, Gouy S, Morice P, Ray-Coquard I, McCluggage WG (2021) Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors. Am J Surg Pathol. 45(2):223\u2013229. https:\/\/doi.org\/10.1097\/PAS.0000000000001582","journal-title":"Am J Surg Pathol."},{"issue":"8","key":"3710_CR26","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1158\/1078-0432.CCR-21-3394","volume":"28","author":"G Jour","year":"2022","unstructured":"Jour G, Vougiouklakis T, Zhu K, Vasudevaraja V, Serrano J, Shen G, Linn RL, Feng X, Chiang S, Barroeta JE, Thomas KM, Schwartz LE, Shukla PS, Malpica A, Oliva E, Cotzia P, DeLair DF, Snuderl M (2022) Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements. Clin Cancer Res. 28(8):1724\u20131733. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3394","journal-title":"Clin Cancer Res."},{"issue":"2","key":"3710_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/his.13630","volume":"73","author":"F Kommoss","year":"2018","unstructured":"Kommoss F, Wang Y, Karnezis AN, Magrill J, Tessier-Cloutier B, Lum A, Senz J, Gilks CB, McCluggage WG, Huntsman DG (2018) DICER1 hot-spot mutations in ovarian gynandroblastoma. Histopathol. 73(2):306\u2013313. https:\/\/doi.org\/10.1111\/his.13630","journal-title":"Histopathol."},{"issue":"1","key":"3710_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0002-9440(10)64735-9.PMID10623683;PMCIDPMC1868646","volume":"156","author":"K Cho","year":"2000","unstructured":"Cho K, Connolly DC, Katabuchi H, Cliby WA (2000) Somatic mutations in the STK11\/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher\u2019s syndrome. Am J Pathol. 156(1):339\u201345. https:\/\/doi.org\/10.1016\/S0002-9440(10)64735-9.PMID10623683;PMCIDPMC1868646","journal-title":"Am J Pathol."},{"issue":"8","key":"3710_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/PAS.0000000000001677","volume":"45","author":"E Oliva","year":"2021","unstructured":"Oliva E, Bennett JA, Young RH, Howitt BE, Croce S, Wanjari P, Zhen C, Da Cruz Paula A, Meserve E, Schoolmeester JK, Westbom-Fremer S, Benzi E, Patil NM, Kooreman L, El-Bahrawy M, Zannoni GF, Krausz T, McCluggage WG, Weigelt B, Ritterhouse LL (2021) A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases. Am J Surg Pathol. 45(8):1061\u20131074. https:\/\/doi.org\/10.1097\/PAS.0000000000001677","journal-title":"Am J Surg Pathol."},{"issue":"6","key":"3710_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/his.14616","volume":"80","author":"W McCluggage","year":"2022","unstructured":"McCluggage W, Parra-Herran C (2022) Ovarian microcystic stromal tumour: from morphological observations to syndromic associations. Histopathol. 80(6):898\u2013904. https:\/\/doi.org\/10.1111\/his.14616","journal-title":"Histopathol."},{"issue":"1","key":"3710_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41467-019-13806-x","volume":"11","author":"B Weigelt","year":"2020","unstructured":"Weigelt B, Kim SH, Da Cruz Paula A, Basili T, Dopeso H, Bi R, Pareja F, da Silva EM, Gularte-M\u00e9rida R, Sun Z, Fujisawa S, Smith CG, Ferrando L, Martins Sebasti\u00e3o AP, Bykov Y, Li A, Silveira C, Ashley CW, Stylianou A, Selenica P, Samore WR, Jungbluth AA, Zamarin D, Soslow A (2020) Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary. Nat Commun. 11(1):44. https:\/\/doi.org\/10.1038\/s41467-019-13806-x","journal-title":"Nat Commun."},{"issue":"10","key":"3710_CR32","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/cncr.25794","volume":"117","author":"A Lopez-Beltran","year":"2011","unstructured":"Lopez-Beltran A, Cheng L, Roth LM, Zhang S, Wang M, Morton MJ, Zheng W, Abdul Karim FW, Montironi R (2011) KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer. 117(10):2096\u2013103. https:\/\/doi.org\/10.1002\/cncr.25794","journal-title":"Cancer."},{"issue":"1","key":"3710_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ygyno.2018.08.013","volume":"151","author":"I Vergote","year":"2018","unstructured":"Vergote I, Van Nieuwenhuysen E, Busschaert P, Neven P, Han SN, Moerman P, Liontos M, Papaspirou M, Kupryjanczyk J, Hogdall C, Hogdall E, Oaknin A, Garcia A, Mahner S, Trillsch F, Cibula D, Heitz F, Concin N, Speiser P, Salvesen H, Sehouli J, Lambrechts D (2018) The genetic landscape of 87 ovarian germ cell tumors. Gynecol Oncol. 151(1):61\u201368. https:\/\/doi.org\/10.1016\/j.ygyno.2018.08.013","journal-title":"Gynecol Oncol."},{"issue":"6","key":"3710_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41379-019-0446-y","volume":"33","author":"R Cho","year":"2020","unstructured":"Cho R, Heskett MB, Sanborn JZ, Boniface C, Goode B, Chapman J, Garg K, Rabban JT, Zaloudek C, Benz SC, Spellman PT, Solomon DA (2020) Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components. Mod Pathol. 33(6):1193\u20131206. https:\/\/doi.org\/10.1038\/s41379-019-0446-y","journal-title":"Mod Pathol."},{"key":"3710_CR35","doi-asserted-by":"publisher","unstructured":"Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, McEachron TA, Salhia B, Prat J, D\u2019Angelo E, Clarke BA, Pressey JG, Farley JH, Anthony SP, Roden RB, Cunliffe HE, Huntsman DG, Trent JM (2014) Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet 46(5):427\u2013429. https:\/\/doi.org\/10.1038\/ng.2928","DOI":"10.1038\/ng.2928"},{"issue":"5","key":"3710_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.2931","volume":"46","author":"W Foulkes","year":"2014","unstructured":"Foulkes W, Witkowski L, Carrot-Zhang J, Albrecht S, Fahiminiya S, Hamel N, Tomiak E, Grynspan D, Saloustros E, Nadaf J, Rivera B, Gilpin C, Castellsagu\u00e9 E, Silva-Smith R, Plourde F, Wu M, Saskin A, Arseneault M, Karabakhtsian RG, Reilly EA, Ueland FR, Margiolaki A (2014) Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 46(5):438\u201343. https:\/\/doi.org\/10.1038\/ng.2931","journal-title":"Nat Genet."},{"issue":"3","key":"3710_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.4633","volume":"238","author":"D Huntsman","year":"2016","unstructured":"Huntsman D, Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D\u2019Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, Rabban JT, Bowtell DD, Weissman BE, Trent JM, Gilks CB (2016) Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol. 238(3):389\u2013400. https:\/\/doi.org\/10.1002\/path.4633","journal-title":"J Pathol."},{"issue":"15","key":"3710_CR38","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","volume":"26","author":"B Weissman","year":"2020","unstructured":"Weissman B, Tischkowitz M, Huang S, Banerjee S, Hague J, Hendricks WPD, Huntsman DG, Lang JD, Orlando KA, Oza AM, Pautier P, Ray-Coquard I, Trent JM, Witcher M, Witkowski L, McCluggage WG, Levine DA, Foulkes WD (2020) Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines. Clin Cancer Res. 26(15):3908\u20133917. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3797","journal-title":"Clin Cancer Res."},{"issue":"6","key":"3710_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/PGP.0000000000000368","volume":"36","author":"G Palmieri","year":"2017","unstructured":"Palmieri G, Cossu A, Casula M, Paliogiannis P, Tanda F, Palomba G, Sini MC, Pisano M, Doneddu V (2017) Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series With Next-Generation Sequencing Mutation Analysis. Int J Gynecol Pathol. 36(6):575\u2013581. https:\/\/doi.org\/10.1097\/PGP.0000000000000368","journal-title":"Int J Gynecol Pathol."},{"issue":"6","key":"3710_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/PGP.0000000000000545","volume":"38","author":"B Howitt","year":"2019","unstructured":"Howitt B, Mirkovic J, Dong F, Sholl LM, Garcia E, Lindeman N, MacConaill L, Crum CP, Nucci MR, McCluggage WG (2019) Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO). Int J Gynecol Pathol. 38(6):543\u2013551. https:\/\/doi.org\/10.1097\/PGP.0000000000000545","journal-title":"Int J Gynecol Pathol."},{"issue":"7","key":"3710_CR41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.humpath.2010.11.001","volume":"42","author":"J Pfeifer","year":"2011","unstructured":"Pfeifer J, Amador-Ortiz C, Roma AA, Huettner PC, Becker N (2011) JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma. Hum Pathol. 42(7):939\u201346. https:\/\/doi.org\/10.1016\/j.humpath.2010.11.001","journal-title":"Hum Pathol."},{"issue":"3","key":"3710_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/gcc.23109","volume":"62","author":"C Antonescu","year":"2023","unstructured":"Antonescu C, Dermawan JK, Dashti N, Chiang S, Turashvili G, Dickson BC, Ellenson LH, Kirchner M, Stenzinger A, Mechtersheimer G, Agaimy A (2023) Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4\/TIP60 as alternative fusion partners. Genes Chromosom. Cancer. 62(3):152\u2013160. https:\/\/doi.org\/10.1002\/gcc.23109","journal-title":"Genes Chromosom. Cancer."},{"issue":"11","key":"3710_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/gcc.22668","volume":"57","author":"T Enomoto","year":"2018","unstructured":"Enomoto T, Tamura R, Nakaoka H, Yoshihara K, Mori Y, Yachida N, Nishikawa N, Motoyama T, Okuda S, Inoue I (2018) Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma. Genes Chromosom. Cancer. 57(11):557\u2013563. https:\/\/doi.org\/10.1002\/gcc.22668","journal-title":"Genes Chromosom. Cancer."},{"issue":"5","key":"3710_CR44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/PGP.0000000000000431","volume":"37","author":"J Schoolmeester","year":"2018","unstructured":"Schoolmeester J, Fang H, Langstraat CL, Visscher DW, Folpe AL (2018) Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case. Int J Gynecol Pathol. 37(5):468\u2013472. https:\/\/doi.org\/10.1097\/PGP.0000000000000431","journal-title":"Int J Gynecol Pathol."},{"issue":"6","key":"3710_CR45","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00428-023-03546-1","volume":"482","author":"A Trecourt","year":"2023","unstructured":"Trecourt A, Macagno N, Ngo C, Philip CA, Lopez J, Ferreira J, Alves-Vale C, Ray-Coquard I, Genestie C, Agaimy A, Devouassoux-Shisheboran M (2023) CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype. Virchows Arch 482(6):967\u2013974. https:\/\/doi.org\/10.1007\/s00428-023-03546-1","journal-title":"Virchows Arch"},{"key":"3710_CR46","unstructured":"WHO Classification of Tumours Editorial Board (2020) Female genital tumours. In: WHO classification of tumours, 5th edn, vol 4. International Agency for Research, Lyon.\u00a0 http:\/\/publications.iarc.fr\/592"},{"issue":"3","key":"3710_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01.pas.0000152136.81771.12","volume":"29","author":"B Ronnett","year":"2005","unstructured":"Ronnett B, Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ (2005) Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol. 29(3):281\u201394. https:\/\/doi.org\/10.1097\/01.pas.0000152136.81771.12","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"3710_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21387","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3710_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A et al (2015) A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer 113(2):299\u2013310. https:\/\/doi.org\/10.1038\/bjc.2015.190","journal-title":"Br J Cancer"},{"issue":"7447","key":"3710_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"The Cancer Genome Atlas Research Network","year":"2013","unstructured":"The Cancer Genome Atlas Research Network (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67\u201373. https:\/\/doi.org\/10.1038\/nature12113","journal-title":"Nature"},{"issue":"4","key":"3710_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.semdp.2010.09.001","volume":"27","author":"A Azueta","year":"2010","unstructured":"Azueta A, Gatius S, Matias-Guiu X (2010) Endometrioid carcinoma of the endometrium: Pathologic and molecular features. Semin. Diagn. Pathol. 27(4):226\u201340. https:\/\/doi.org\/10.1053\/j.semdp.2010.09.001","journal-title":"Semin. Diagn. Pathol."},{"issue":"3","key":"3710_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00428-013-1509-y","volume":"464","author":"X Matias-Guiu","year":"2014","unstructured":"Matias-Guiu X, Davidson B (2014) Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Archiv 464(3):315\u201331. https:\/\/doi.org\/10.1007\/s00428-013-1509-y","journal-title":"Virchows Archiv"},{"issue":"1","key":"3710_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/his.12053","volume":"62","author":"X Matias-Guiu","year":"2013","unstructured":"Matias-Guiu X, Prat J (2013) Molecular pathology of endometrial carcinoma. Histopathology 62(1):111\u201323. https:\/\/doi.org\/10.1111\/his.12053","journal-title":"Histopathology"},{"issue":"3","key":"3710_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/s0046-8177(00)80244-0","volume":"31","author":"E Bussaglia","year":"2000","unstructured":"Bussaglia E, Del Rio E, Matias-Guiu X, Prat J (2000) PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases. Hum. Pathol 31(3):312\u20137. https:\/\/doi.org\/10.1016\/s0046-8177(00)80244-0","journal-title":"Hum. Pathol"},{"issue":"2","key":"3710_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH769>3.0.CO;2-9","volume":"193","author":"H Lagarda","year":"2001","unstructured":"Lagarda H, Catasus L, Arguelles R, Matias-Guiu X, Prat J (2001) K-ras mutations in endometrial carcinomas with microsatellite instability. J. Pathol. 193(2):193\u20139. https:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999%3c::AID-PATH769%3e3.0.CO;2-9","journal-title":"J. Pathol."},{"issue":"2","key":"3710_CR56","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/hupa.2002.30723","volume":"33","author":"P Machin","year":"2002","unstructured":"Machin P, Catasus L, Pons C, Munoz J, Matias-Guiu X, Prat J (2002) CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 33(2):206\u201312. https:\/\/doi.org\/10.1053\/hupa.2002.30723","journal-title":"Hum Pathol"},{"key":"3710_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","volume":"154","author":"N Concin","year":"2021","unstructured":"Concin N et al (2021) ESGO\/ESTRO\/ESP Guidelines for the management of patients with endometrial carcinoma. Radiother Oncol 154:327\u2013353. https:\/\/doi.org\/10.1016\/j.radonc.2020.11.018","journal-title":"Radiother Oncol"},{"issue":"18","key":"3710_CR58","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/cncr.32203","volume":"125","author":"MelissaK Frey","year":"2019","unstructured":"Frey MelissaK, Kahn Ryan M, Gordhandas Sushmita, Maddy Brandon Paul, Nelson Becky Baltich, Askin Gulce, Christos Paul J, Caputo Thomas A, Chapman-Davis Eloise, Holcomb Kevin (2019) Universal Endometrial Cancer Tumor Typing: How Much Has Immunohistochemistry, Microsatellite Instability, and MLH1 Methylation Improved the Diagnosis of Lynch Syndrome Across the Population? Cancer 125(18):3172\u20133183. https:\/\/doi.org\/10.1002\/cncr.32203","journal-title":"Cancer"},{"issue":"3","key":"3710_CR59","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/PAS.0000000000001832","volume":"46","author":"G Turashvili","year":"2022","unstructured":"Turashvili G, Mrkonjic M (2022) EPM2AIP1 Immunohistochemistry Can Be Used as Surrogate Testing for MLH1 Promoter Methylation in Endometrial Cancer. Am J Surg Pathol. 46(3):376\u2013382. https:\/\/doi.org\/10.1097\/PAS.0000000000001832","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"3710_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ygyno.2021.08.008","volume":"163","author":"BL Manning-Geist","year":"2021","unstructured":"Manning-Geist BL et al (2021) Diagnosis and management of an endometrial cancer patient with Cowden syndrome. Gynecol Oncol 163(1):14\u201321. https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.008","journal-title":"Gynecol Oncol"},{"key":"3710_CR61","doi-asserted-by":"publisher","unstructured":"Mendelsohn J, Howley PM, Israel MA, Gray JW, Thompson CB (2008) The molecular basis of cancer. Elsevier Inc. https:\/\/doi.org\/10.1016\/B978-1-4160-3703-3.X5001-7","DOI":"10.1016\/B978-1-4160-3703-3.X5001-7"},{"issue":"4","key":"3710_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2012.76","volume":"32","author":"A Yeramian","year":"2013","unstructured":"Yeramian A et al (2013) Endometrial carcinoma: Molecular alterations involved in tumor development and progression. Oncogene. 32(4):403\u201313. https:\/\/doi.org\/10.1038\/onc.2012.76","journal-title":"Oncogene."},{"issue":"11","key":"3710_CR63","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/1878-0261.13193","volume":"16","author":"C Megino-Luque","year":"2022","unstructured":"Megino-Luque C et al (2022) ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. Mol. Oncol 16(11):2235\u20132259. https:\/\/doi.org\/10.1002\/1878-0261.13193","journal-title":"Mol. Oncol"},{"key":"3710_CR64","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/modpathol.2015.141","volume":"1","author":"S Gatius","year":"2016","unstructured":"Gatius S, Matias-Guiu X (2016) Practical issues in the diagnosis of serous carcinoma of the endometrium. Modern Pathology. 1:S45-58. https:\/\/doi.org\/10.1038\/modpathol.2015.141","journal-title":"Modern Pathology."},{"issue":"1","key":"3710_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/excr.2000.5141","volume":"264","author":"DB Woods","year":"2001","unstructured":"Woods DB, Vousden KH (2001) Regulation of p53 function. Exp Cell Res 264(1):56\u201366. https:\/\/doi.org\/10.1006\/excr.2000.5141","journal-title":"Exp Cell Res"},{"issue":"11","key":"3710_CR66","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-x","volume":"26","author":"ME Sherman","year":"1995","unstructured":"Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum. Pathol 26(11):1268\u201374. https:\/\/doi.org\/10.1016\/0046-8177(95)90204-x","journal-title":"Hum. Pathol"},{"issue":"9","key":"3710_CR67","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/jcp.2008.056101","volume":"62","author":"D Llobet","year":"2009","unstructured":"Llobet D et al (2009) Molecular pathology of endometrial carcinoma: Practical aspects from the diagnostic and therapeutic viewpoints. Journal of Clinical Pathology. 62(9):777\u201385. https:\/\/doi.org\/10.1136\/jcp.2008.056101","journal-title":"Journal of Clinical Pathology."},{"issue":"69","key":"3710_CR68","doi-asserted-by":"publisher","first-page":"114371","DOI":"10.18632\/oncotarget.22825","volume":"8","author":"R Mishra","year":"2017","unstructured":"Mishra R, Hanker AB, Garrett JT (2017) Genomic alterations of ERBB receptors in cancer: clinical implications. Oncotarget 8(69):114371\u2013114392. https:\/\/doi.org\/10.18632\/oncotarget.22825","journal-title":"Oncotarget"},{"key":"3710_CR69","doi-asserted-by":"publisher","unstructured":"Chiesa-Vottero AG, Malpica A, Deavers MT, Broaddus R, Nuovo GJ, Silva EG (2007) Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol 26(3):328\u2013333. https:\/\/doi.org\/10.1097\/01.pgp.0000235065.31301.3e","DOI":"10.1097\/01.pgp.0000235065.31301.3e"},{"issue":"10","key":"3710_CR70","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","volume":"33","author":"A Yemelyanova","year":"2009","unstructured":"Yemelyanova A, Ji H, Shih IM, Wang TL, Wu LSF, Ronnett BM (2009) Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: Immunohistochemical analysis of 201 cases. Am. J. Surg. Pathol. 33(10):1504\u201314. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ac35f5","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"3710_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/modpathol.2010.41","volume":"23","author":"LJ Tafe","year":"2010","unstructured":"Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA (2010) Endometrial and ovarian carcinomas with undifferentiated components: Clinically aggressive and frequently underrecognized neoplasms. Mod. Pathol. 23(6):781\u20139. https:\/\/doi.org\/10.1038\/modpathol.2010.41","journal-title":"Mod. Pathol."},{"issue":"2","key":"3710_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cjp2.188","volume":"7","author":"C Lee","year":"2021","unstructured":"Lee C, Tessier-Cloutier B, Coatham M, Carey M, Nelson GS, Hamilton S, Lum A, Soslow RA, Stewart CJ, Postovit LM, K\u00f6bel M (2021) SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma. J Pathol Clin Res 7(2):144\u2013153. https:\/\/doi.org\/10.1002\/cjp2.188","journal-title":"J Pathol Clin Res"},{"issue":"7","key":"3710_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1933719110368433","volume":"17","author":"M RuhulQuddus","year":"2010","unstructured":"RuhulQuddus M, Sung CJ, Zhang Cunxian, Dwayne Lawrence W (2010) Minor serous and clear cell components adversely affect prognosis in mixed-type endometrial carcinomas: A clinicopathologic study of 36 stage-I cases. Reprod. Sci. 17(7):673\u20138. https:\/\/doi.org\/10.1177\/1933719110368433","journal-title":"Reprod. Sci."},{"issue":"13","key":"3710_CR74","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41388-022-02221-0","volume":"41","author":"G Moreno-Bueno","year":"2022","unstructured":"Moreno-Bueno G, Mota A, Oltra SS, Selenica P, Moiola CP, Casas-Arozamena C, L\u00f3pez-Gil C, Diaz E, Gatius S, Ruiz-Miro M, Calvo A, Rojo-Sebasti\u00e1n A, Hurtado P, Pi\u00f1eiro R, Colas E, Gil-Moreno A, Reis-Filho JS, Muinelo-Romay L, Abal M, Matias-Guiu X, Weigelt B (2022) Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression. Oncogene. 41(13):1835\u20131850. https:\/\/doi.org\/10.1038\/s41388-022-02221-0","journal-title":"Oncogene."},{"issue":"1","key":"3710_CR75","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.2802","volume":"223","author":"J Palacios","year":"2011","unstructured":"Palacios J, Castilla M\u00c1, Moreno-Bueno G, Romero-P\u00e9rez L, Van De Vijver K, Biscuola M, L\u00f3pez-Garc\u00eda M\u00c1, Prat J, Mat\u00edas-Guiu X, Cano A, Oliva E (2011) Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol. 223(1):72\u201380. https:\/\/doi.org\/10.1002\/path.2802","journal-title":"J Pathol."},{"issue":"1","key":"3710_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004347-199501000-00005","volume":"14","author":"KH van Hoeven","year":"1995","unstructured":"van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ (1995) Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 14(1):21\u201329. https:\/\/doi.org\/10.1097\/00004347-199501000-00005","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"3710_CR77","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0973-1482.82942","volume":"7","author":"KK Deodhar","year":"2011","unstructured":"Deodhar KK, Kerkar Ra, Suryawanshi P, Menon H, Menon S (2011) Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J. Cancer Res. Ther. 7(2):211\u20133. https:\/\/doi.org\/10.4103\/0973-1482.82942","journal-title":"J. Cancer Res. Ther."},{"issue":"4","key":"3710_CR78","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","volume":"45","author":"L Hoang","year":"2021","unstructured":"Hoang L, Pors J, Segura S, Chiu DS, Almadani N, Ren H, Fix DJ, Howitt BE, Kolin D, McCluggage WG, Mirkovic J, Gilks B, Park KJ (2021) Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study. Am J Surg Pathol. 45(4):498\u2013506","journal-title":"Am J Surg Pathol."},{"issue":"8","key":"3710_CR79","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","volume":"34","author":"K Park","year":"2021","unstructured":"Park K, da Silva EM, Fix DJ, Sebastiao APM, Selenica P, Ferrando L, Kim SH, Stylianou A, Da Cruz Paula A, Pareja F, Smith ES, Zehir A, Konner JA, Cadoo K, Reis-Filho JS, Abu-Rustum NR, Mueller JJ, Weigelt B (2021) Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol. 34(8):1570\u20131587. https:\/\/doi.org\/10.1038\/s41379-021-00799-6","journal-title":"Mod Pathol."},{"issue":"3","key":"3710_CR80","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/PAS.0000000000001381","volume":"44","author":"W McCluggage","year":"2020","unstructured":"McCluggage W, Wong RW, Ralte A, Grondin K, Talia KL (2020) Endometrial Gastric (Gastrointestinal)-type Mucinous Lesions: Report of a Series Illustrating the Spectrum of Benign and Malignant Lesions. Am J Surg Pathol. 44(3):406\u2013419. https:\/\/doi.org\/10.1097\/PAS.0000000000001381","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"3710_CR81","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.5373","volume":"250","author":"T Bosse","year":"2020","unstructured":"Bosse T, Le\u00f3n-Castillo A, Gilvazquez E, Nout R, Smit VT, McAlpine JN, McConechy M, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT, Soslow RA, Ganesan R, Matias-Guiu X, Oliva E, Harrison BT, Church DN, Gilks CB (2020) Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas. J Pathol 250(3):312\u2013322","journal-title":"J Pathol"},{"issue":"5","key":"3710_CR82","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","volume":"34","author":"N Concin","year":"2023","unstructured":"Concin N, Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D (2023) Endometrial Cancer Staging Subcommittee, FIGO Women\u2019s Cancer Committee. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obs. 34(5):e85. https:\/\/doi.org\/10.3802\/jgo.2023.34.e85","journal-title":"Int J Gynaecol Obs."},{"issue":"5","key":"3710_CR83","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","volume":"42","author":"T Bosse","year":"2018","unstructured":"Bosse T et al (2018) Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups. Am. J. Surg. Pathol. 42(5):561\u2013568. https:\/\/doi.org\/10.1097\/PAS.0000000000001020","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"3710_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.5372","volume":"250","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo A et al (2020) Interpretation of somatic POLE mutations in endometrial carcinoma. J. Pathol. 250(3):323\u2013335. https:\/\/doi.org\/10.1002\/path.5372","journal-title":"J. Pathol."},{"issue":"14","key":"3710_CR85","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/cncr.33516","volume":"127","author":"A Talhouk","year":"2021","unstructured":"Talhouk A, McAlpine JN, Chiu DS, Nout RA, Church DN, Schmidt P, Lam S, Leung S, Bellone S, Wong A, Brucker SY, Lee CH, Clarke BA, Huntsman DG, Bernardini MQ, Ngeow J, Santin AD, Goodfellow P, Levine DA, K\u00f6bel M, Kommoss S, Bosse T, Gilks CB (2021) Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis. Cancer. 127(14):2409\u20132422","journal-title":"Cancer."},{"key":"3710_CR86","doi-asserted-by":"publisher","first-page":"1147657","DOI":"10.3389\/fonc.2023.1147657","volume":"13","author":"C Cosgrove","year":"2023","unstructured":"Cosgrove C, Riedinger CJ, Brown M, Haight PJ, Backes FJ, Cohn DE, Goodfellow PJ (2023) Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer. Front Oncol. 13:1147657. https:\/\/doi.org\/10.3389\/fonc.2023.1147657","journal-title":"Front Oncol."},{"issue":"6","key":"3710_CR87","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.3802\/jgo.2021.32.e79","volume":"32","author":"Y Terada","year":"2021","unstructured":"Terada Y, Kaneko E, Sato N, Sugawara T, Noto A, Takahashi K, Makino K (2021) MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas. J Gynecol Oncol. 32(6):e79","journal-title":"J Gynecol Oncol."},{"issue":"6","key":"3710_CR88","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/cncr.34025","volume":"128","author":"A Santin","year":"2022","unstructured":"Santin A, Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Yong Al (2022) A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. Cancer. 128(6):1206\u20131218","journal-title":"Cancer."},{"issue":"2","key":"3710_CR89","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2159-8290.CD-22-0686","volume":"13","author":"A Santin","year":"2023","unstructured":"Santin A, Chow RD, Michaels T, Bellone S, Hartwich TMP, Bonazzoli E, Iwasaki A, Song E (2023) Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma. Cancer Discov. 13(2):312\u2013331","journal-title":"Cancer Discov."},{"issue":"9","key":"3710_CR90","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41379-022-01066-y","volume":"35","author":"R Soslow","year":"2022","unstructured":"Soslow R, Momeni-Boroujeni A, Nguyen B, Vanderbilt CM, Ladanyi M, Abu-Rustum NR, Aghajanian C, Ellenson LH, Weigelt B (2022) Genomic landscape of endometrial carcinomas of no specific molecular profile. Mod Pathol. 35(9):1269\u20131278","journal-title":"Mod Pathol."},{"issue":"7","key":"3710_CR91","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","volume":"128","author":"T Bosse","year":"2023","unstructured":"Bosse T, Vermij L, Jobsen JJ, Le\u00f3n-Castillo A, Brinkhuis M, Roothaan S, Powell ME, de Boer SM, Khaw P, Mileshkin LR, Fyles A, Leary A, Genestie C, J\u00fcrgenliemk-Schulz IM, Crosbie EJ, Mackay HJ, Nijman HW, Nout RA, Smit VTHBM, Creutzberg CL, Horeweg N, Ver Bosse TP- (2023) TransPORTEC Consortium. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. Br J Cancer. 128(7):1360\u20131368","journal-title":"Br J Cancer."},{"issue":"4","key":"3710_CR92","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.modpat.2022.100085","volume":"36","author":"J McAlpine","year":"2023","unstructured":"McAlpine J, Jamieson A, Huvila J, Chiu D, Thompson EF, Scott S, Salvador S, Vicus D, Helpman L, Gotlieb W, Kean S, Samouelian V, K\u00f6bel M, Kinloch M, Parra-Harran C, Offman S, Grondin K, Irving J, Lum A, Senz J, Leung S, McConechy MK, Plante M, Kommoss S, Huntsman DG (2023) Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. Mod Pathol. 36(4):100085","journal-title":"Mod Pathol."},{"issue":"2","key":"3710_CR93","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PGP.0000000000000674","volume":"40","author":"M K\u00f6bel","year":"2021","unstructured":"K\u00f6bel M, Brett MA, Atenafu EG, Singh N, Ghatage P, Clarke BA, Nelson GS, Bernardini MQ (2021) Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma. Int J Gynecol Pathol. 40(2):116\u2013123","journal-title":"Int J Gynecol Pathol."},{"issue":"11","key":"3710_CR94","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/modpathol.2016.135","volume":"29","author":"R Broaddus","year":"2016","unstructured":"Broaddus R, Ring KL, Bruegl AS, Allen BA, Elkin EP, Singh N, Hartman AR, Daniels MS (2016) Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Mod Pathol. 29(11):1381\u20131389. https:\/\/doi.org\/10.1038\/modpathol.2016.135","journal-title":"Mod Pathol."},{"issue":"24","key":"3710_CR95","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.1158\/1078-0432.CCR-19-0848","volume":"25","author":"THG Bosse","year":"2019","unstructured":"Bosse THG, de Jonge MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, Segal JP, Puranik R, Hollema H, Rookus MA, van Asperen CJ, van Leeuwen FE, Smit VTHBM, Howitt BE (2019) Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity. Clin Cancer Res. 25(24):7517\u20137526. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0848","journal-title":"Clin Cancer Res."},{"issue":"3","key":"3710_CR96","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ygyno.2020.12.010","volume":"160","author":"A Sood","year":"2021","unstructured":"Sood A, Siedel JH, Ring KL, Hu W, Dood RL, Wang Y, Baggerly K, Darcy KM, Conrads TP, Gallagher S, Tshiaba P, Neff C, Timms KM, Mangala S, Westin SN, Broaddus R, Lopez-Berestein G, Lu KH, Coleman RL, Maxwell GL (2021) Clinical significance of homologous recombination deficiency score testing in endometrial Cancer. Gynecol Oncol. 160(3):777\u2013785. https:\/\/doi.org\/10.1016\/j.ygyno.2020.12.010","journal-title":"Gynecol Oncol."},{"issue":"1","key":"3710_CR97","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2018.10.032","volume":"152","author":"B Weigelt","year":"2019","unstructured":"Weigelt B, Ashley CW, Da Cruz Paula A, Kumar R, Mandelker D, Pei X, Riaz N, Reis-Filho JS (2019) Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. Gynecol Oncol. 152(1):11\u201319. https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.032","journal-title":"Gynecol Oncol."},{"issue":"3","key":"3710_CR98","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-18-1443","volume":"25","author":"T Bosse","year":"2019","unstructured":"Bosse T, de Jonge MM, Auguste A, van Wijk LM, Schouten PC, Meijers M, Ter Haar NT, Smit VTHBM, Nout RA, Glaire MA, Church DN, Vrieling H, Job B, Boursin Y, de Kroon CD, Rouleau E, Leary A, Vreeswijk MPG (2019) Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas. Clin Cancer Res. 25(3):1087\u20131097. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1443","journal-title":"Clin Cancer Res."},{"issue":"2","key":"3710_CR99","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/cancers13020254","volume":"13","author":"I Hedenfalk","year":"2021","unstructured":"Hedenfalk I, J\u00f6nsson JM, B\u00e5\u00e5th M, Bj\u00f6rnheden I, Sahin ID, M\u00e5sb\u00e4ck A (2021) Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer. Cancers (Basel). 13(2):254. https:\/\/doi.org\/10.3390\/cancers13020254","journal-title":"Cancers (Basel)."},{"key":"3710_CR100","doi-asserted-by":"publisher","unstructured":"Buza N, Euscher ED, Matias-Guiu X, McHenry A, Oliva E, Ordulu Z, Parra-Herran C, Rottmann D, Turner BM, Wong S, Hui P (2021) Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study. Mod Pathol 34(6):1194\u20131202. https:\/\/doi.org\/10.1038\/s41379-021-00746-5","DOI":"10.1038\/s41379-021-00746-5"},{"issue":"3","key":"3710_CR101","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/his.14001","volume":"76","author":"X Matias-Guiu","year":"2020","unstructured":"Matias-Guiu X, Cuevas D, Velasco A, Vaquero M, Santacana M, Gatius S, Eritja N, Estaran E (2020) Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study. Histopathol. 76(3):447\u2013460","journal-title":"Histopathol."}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03710-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03710-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T12:06:46Z","timestamp":1710763606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03710-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03710-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}